Evidence map›Paper›PMID 19153220›Full record

ArticleThe Journal of cell biology2009

Essential and unique roles of PIP5K-gamma and -alpha in Fcgamma receptor-mediated phagocytosis.

Yuntao S Mao, Masaki Yamaga, Xiaohui Zhu, Yongjie Wei, Hui-Qiao Sun, Jing Wang, Mia Yun, Yanfeng Wang, Gilbert Di Paolo, Michael Bennett and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
11.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 95 citations in OpenAlex.

  1. PIP4K attenuates PIP5K lipid kinase activity by disrupting membrane-mediated dimerization.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Local PI(4,5)PNature communications · 2026
    Article
  3. Article
  4. PI(4,5)PBiochimica et biophysica acta. Molecular and cell biology of lipids · 2025
    Review
  5. Review
  6. Article
  7. Microbiology spectrum · 2023
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. The multifaceted role of PIP2 in leukocyte biology.Cellular and molecular life sciences : CMLS · 2015
    Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Phosphoinositides and engulfment.Cellular microbiology · 2014
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Yuntao S MaoDepartment of Physiology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Masaki Yamaga
Xiaohui Zhu
Yongjie Wei
Hui-Qiao Sun
Jing Wang
Mia Yun
Yanfeng Wang
Gilbert Di Paolo
Michael Bennett
Ira Mellman
Charles S Abrams
Pietro De Camilli
Christopher Y Lu
Helen L Yin
Czech Academy of Sciences, Institute of Physiology · CZThe University of Texas Southwestern Medical Center · USUniversity of Pennsylvania · USColumbia University · USHoward Hughes Medical Institute · US

Funding

Yale/NIDA Neuroproteomics Research CenterP30DA018343 · NIDA · YALE UNIVERSITY · PI Marina R Picciotto · 2004 to 2026
$37.1M
Subcellular Mechanisms pf Platelet ActivationP01HL040387 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI BENNETT, JOEL S. · 1988 to 2018
$35.5M
SIGNAL REGULATION OF CARDIAC CYTOKINE SYNTHESIS AND MECHANICAL FUNCTIONP50GM021681 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI NWARIAKU, FIEMU E. · 1985 to 2009
$12.8M
Role of phospholipids in membrane traffic at the synapseR01NS056049 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LIEM, RONALD K. · 2006 to 2016
$3.7M
The roles of pleckstrin and pleckstrin-2 in platelet biologyR01HL083392 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI ABRAMS, CHARLES S. · 2006 to 2013
$3.2M
TLR4 and murine ischemic acute renal failureR01DK069633 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI LU, CHRISTOPHER Y. · 2006 to 2010
$1.6M
NCI NIH HHS R01 CA 03922-24NHLBI NIH HHS P01 HL040387NHLBI NIH HHS P01 HL 40387NHLBI NIH HHS R01 HL 083392NHLBI NIH HHS R01 HL083392NIDA NIH HHS P30 DA018343NIDDK NIH HHS R01 DK 069633NIDDK NIH HHS R01 DK069633NIGMS NIH HHS P50 GM021681NIGMS NIH HHS P50 GM 21681NIGMS NIH HHS R01 GM 06110NINDS NIH HHS R01 NS 056049NINDS NIH HHS R01 NS056049
6 · The paper itself

Abstract

The actin cytoskeleton is dynamically remodeled during Fcgamma receptor (FcgammaR)-mediated phagocytosis in a phosphatidylinositol (4,5)-bisphosphate (PIP(2))-dependent manner. We investigated the role of type I phosphatidylinositol 4-phosphate 5-kinase (PIP5K) gamma and alpha isoforms, which synthesize PIP(2), during phagocytosis. PIP5K-gamma-/- bone marrow-derived macrophages (BMM) have a highly polymerized actin cytoskeleton and are defective in attachment to IgG-opsonized particles and FcgammaR clustering. Delivery of exogenous PIP(2) rescued these defects. PIP5K-gamma knockout BMM also have more RhoA and less Rac1 activation, and pharmacological manipulations establish that they contribute to the abnormal phenotype. Likewise, depletion of PIP5K-gamma by RNA interference inhibits particle attachment. In contrast, PIP5K-alpha knockout or silencing has no effect on attachment but inhibits ingestion by decreasing Wiskott-Aldrich syndrome protein activation, and hence actin polymerization, in the nascent phagocytic cup. In addition, PIP5K-gamma but not PIP5K-alpha is transiently activated by spleen tyrosine kinase-mediated phosphorylation. We propose that PIP5K-gamma acts upstream of Rac/Rho and that the differential regulation of PIP5K-gamma and -alpha allows them to work in tandem to modulate the actin cytoskeleton during the attachment and ingestion phases of phagocytosis.

Indexed as

PhagocytosisActinsAnimalsHumansMacrophagesMiceMice, TransgenicPhosphorylationPhosphotransferases (Alcohol Group Acceptor)Protein IsoformsReceptors, IgG1-phosphatidylinositol-4-phosphate 5-kinaseActinsPhosphotransferases (Alcohol Group Acceptor)Protein IsoformsReceptors, IgG

Identifiers

PMID19153220
PMCPMC2654300
OpenAlexW2120848575

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.